Mayo Clinic May 26, 2024
John Halamka

A closer look at the latest FDA list of approved AI-enabled devices suggests these digital tools are poised to have a significant impact on patient care.

By John Halamka, M.D., President, Mayo Clinic Platform and Paul Cerrato, MA, senior research analyst and communications specialist, Mayo Clinic Platform

There was a time in the not-too-distant past when physicians and nurses paid little attention to AI/ML-based medical devices, viewing them as novelties not useful bedside tools. That has drastically changed in the last five years. Consider the latest list of such medical devices, updated in May 2024 and published by the FDA. It includes devices that were marketed via 510k clearance, DeNovo request, and premarket approval.

The majority of these digital...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Patient / Consumer, Physician, Provider, Technology
How AI will change the way you use your browser
Humana to Leverage Google Cloud’s GenAI Capabilities to Improve Member Experiences
Eisai adopts Medidata’s AI-driven platform for clinical trials
How Microsoft is turning AI skeptics into AI power users
CMS to reimburse providers for use of AI prostate cancer mapping tool

Share This Article